Ovid Therapeutics Inc.·4

Sep 6, 6:23 PM ET

Ward Ana 4

4 · Ovid Therapeutics Inc. · Filed Sep 6, 2017

Insider Transaction Report

Form 4
Period: 2017-09-05
Ward Ana
SVP and General Counsel
Transactions
  • Award

    Stock Option Grant (Right to Buy)

    2017-09-05+95,00095,000 total
    Exercise: $8.38Exp: 2027-09-04Common Stock (95,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on September 1, 2018 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION